New Afib Drug Treatments & Rhythm Control Use — StopAfib.org Interviews Dr. James Reiffel
New Afib Drug Treatments & Rhythm Control Use — StopAfib.org interviews Dr. James Reiffel – StopAfib interviews Dr. James Reiffel Find a transcript and more on Dr. Reiffel at: www.stopafib.org In this video interview at Heart Rhythm 2012, Dr. James Reiffel updates us on new directions in drug treatments for atrial fibrillation. He talks about the combination of ranolazine (Ranexa) and dronedarone (Multaq), both used in lower doses, and about other coming atrial-selective drugs. He also discusses the rate control vs. rhythm control decision, which varies by age and level of symptoms. Dr. Reiffel is an attending physician at New York Presbyterian Hospital, and a Professor of Clinical Medicine at the Columbia University College of Physicians & Surgeons.
GWB leaping beauty's sad descent into 'faux foe' rage
Filed under: drug rehab treatment ny
Prescription drugs, including Adderall, which is used to treat ADHD, and Klonopin, an anti-panic drug, were found in her bag. Riggitano's suicide notes — written in girlish cursive on lined, loose-leaf paper — revealed the depths of her despair. “To …
Read more on New York Post
Task force would address heroin “epidemic”
Filed under: drug rehab treatment ny
According to data released last year by Roosevelt University's Illinois Consortium on Drug Policy, the Chicago metropolitan area has had more heroin-related emergency room visits than New York City, Boston or Detroit. Buffalo Grove native Chelsea …
Read more on Chicago Daily Herald
"Side Effects": Critics hot for new Steven Soderbergh film
Filed under: drug rehab treatment ny
… follows Emily and Martin (Rooney Mara and Channing Tatum), a successful New York couple whose world gets turned upside down when a new drug prescribed by Emily's psychiatrist (Jude Law) — intended to treat anxiety — has unexpected side effects.
Read more on CBS News
Teva plans to sell Irvine drug plant
Filed under: drug rehab treatment ny
The company said its revenues were hit in the fourth quarter by the advent of a generic alternative to its blockbuster drug Provigil, used to treat certain sleep disorders. Kedra said Teva had sold $ 350 million worth of Provigil in the fourth quarter …
Read more on OCRegister